Literature DB >> 27960568

Altered expression of hormone receptor, integrin β3 and pinopode in the endometrium of luteal phase defect women.

Shuangge Liu1, Teng Hua1, Xiaoyan Xin1, Rui Shi1, Shuqi Chi1, Hongbo Wang1.   

Abstract

OBJECTIVE: To invistigate estrogen receptor (ER), progesterone receptor (PR), integrin β3, and pinopode expression in luteal phase deficiency (LPD) women.
METHODS: There were 52 nulligravidas consecutive infertile patients undergoing a routine assistant reproduction consultation included in this study. An endometrial biopsy sample was randomly obtained between days 4 and 10 of the luteal phase. Endometrial morphology was examined with scanning electron microscopy. Expressions of ER, PR, integrin β3 were determined in the endometrium of LPD patients with immunohistochemistry.
RESULTS: The incidence of LPD was 15.3% (8/52) in this study. On day luteinizing hormone (LH) surge + 9∼LH + 10, noted regressing pinopodes resembling a day LH + 7∼LH + 8 in the endometrium of the control group. The expressions of ER and PR in glandular epithelium were significantly increased in endometrium of LPD than that in the control group (p < 0.05). In contrast, there was a statistically significant decrease expression of the integrin β3 in women from the group of LPD (p < 0.05).
CONCLUSION: The altered expression of ER and PR may be associated with the expression variation of integrin and pinopode formation in endometrium of LPD women. This alteration may imply the association of low rates of cycle fecundity and high rates of embryonic loss in LPD women.

Entities:  

Keywords:  ER; PR; luteal phase defect; pinopodes; window of implantation

Mesh:

Substances:

Year:  2016        PMID: 27960568     DOI: 10.1080/09513590.2016.1259405

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  3 in total

Review 1.  Pinopodes: Recent advancements, current perspectives, and future directions.

Authors:  Kelsey E Quinn; Brooke C Matson; Margeaux Wetendorf; Kathleen M Caron
Journal:  Mol Cell Endocrinol       Date:  2019-11-15       Impact factor: 4.102

2.  NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer.

Authors:  Shuang-Ge Liu; Xiao-Xiong Wu; Teng Hua; Xiao-Yan Xin; Di-Lu Feng; Shu-Qi Chi; Xiao-Xiao Wang; Hong-Bo Wang
Journal:  Onco Targets Ther       Date:  2019-08-27       Impact factor: 4.147

Review 3.  Molecular Signaling Regulating Endometrium-Blastocyst Crosstalk.

Authors:  Micol Massimiani; Valentina Lacconi; Fabio La Civita; Carlo Ticconi; Rocco Rago; Luisa Campagnolo
Journal:  Int J Mol Sci       Date:  2019-12-18       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.